Clinical Trial Update: SPL7013 Gel - Male Tolerance Study [Phase 1]

View source ↗

Summary

Phase 1 male tolerance study of SPL7013 Gel for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SPL7013 Gel (SPL7013)

Snippet

Sponsor: Starpharma Pty Ltd | Conditions: Human Immunodeficiency Virus (HIV) | Phase 1 | Status: COMPLETED